Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Longan Pharmaceutical is a Chinese pharmaceutical company headquartered in Wuhan, Hubei Province, specializing in the research, development, and manufacturing of both chemical drugs and traditional Chinese medicines (TCM). The company operates large-scale production facilities that adhere to national Good Manufacturing Practice (GMP) standards, producing a variety of dosage forms including tablets, capsules, and granules. Its product portfolio primarily addresses therapeutic needs in cardiovascular health, respiratory ailments, and digestive system disorders. Wuhan Longan Pharmaceutical serves as a key regional player in the Hubei pharmaceutical industry, focusing on the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Longan Pharmaceutical.